Alyglo ™ (immune globulin intravenous, human-stwk) 10% liquid is now available for the treatment of primary humoral immunodeficiency (PI) in adult patients 17 years of age and older.
There are two types of immune deficiency, both of which have several causes. Primary immunodeficiency is typically present at birth. Immunocompromised people may have a hereditary disorder or disease.